Global fertility care leader IVI RMA North America announced a partnership with Illume Fertility, Connecticut's leading fertility group, establishing a new presence in the state through Illume's network of five locations across Connecticut and New York.

Lynn Mason, Chief Executive Officer of IVI RMA North America, said, "We're excited to welcome Illume Fertility to the IVI RMA North America family. Illume's reputation for clinical excellence, innovative treatment protocols, and exceptional patient care aligns perfectly with our mission to expand access to top-notch fertility services. This partnership will help us better serve patients throughout the Northeast while maintaining the highest standards of care across our network."

Illume Fertility serves patients across Connecticut and the surrounding region, providing comprehensive reproductive medicine services including IVF, fertility preservation, and donor and third-party reproduction. Its clinical team includes nine fertility specialists board-certified in reproductive endocrinology and infertility as well as obstetrics and gynecology, bringing specialized fellowship training in fertility treatment, hormone regulation, and assisted conception.

"Joining IVI RMA North America marks an exciting next chapter for Illume Fertility," said Dr. Mark Leondires, Medical Director of Illume Fertility. "Our team has always been deeply committed to providing exceptional, holistic, inclusive care to every patient. Partnering with IVI RMA allows us to continue on our mission while giving our patients and the entire Illume team access to a broader network of clinical services, research, and innovation."

The partnership connects Illume with IVI RMA's established operations, building a more integrated fertility network across the Northeast and strengthening access to fertility care for patients building families in Connecticut.

Dr. Thomas Molinaro, Chief Medical Officer, said, "We welcome Illume Fertility's talented team and their patients into the IVI RMA North America family, bringing excellent fertility care and expertise to an expanded network across Connecticut. This new partnership means more patients can benefit from our cutting-edge science and innovation and receive the personalized, individualized care we strive to provide. We look forward to expanding the possibilities for those seeking to build their families in Connecticut."

IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans 27 IVF laboratories and resulted in more than 11,000 births in 2025.